Triferic Pediatric Pharmacokinetic Protocol

The main purpose is to determine the pharmacokinetics (PK) of Triferic iron administered intravenously in pediatric patients with chronic kidney disease on chronic hemodialysis (CKD-5HD). It is an open-label, two-period sequential dosing study.

See detailed information including eligibility.

11/2015
09/2016
NCT02595437
Kidney Disorders, Peds Nephrology
Accepting Participants